These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23117207)

  • 1. The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone.
    Wright T; Rea SL; Goode A; Bennett AJ; Ratajczak T; Long JE; Searle MS; Goldring CE; Park BK; Copple IM; Layfield R
    Bone; 2013 Feb; 52(2):699-706. PubMed ID: 23117207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone.
    Najat D; Garner T; Hagen T; Shaw B; Sheppard PW; Falchetti A; Marini F; Brandi ML; Long JE; Cavey JR; Searle MS; Layfield R
    J Bone Miner Res; 2009 Apr; 24(4):632-42. PubMed ID: 19049332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding.
    Rea SL; Walsh JP; Ward L; Magno AL; Ward BK; Shaw B; Layfield R; Kent GN; Xu J; Ratajczak T
    J Bone Miner Res; 2009 Jul; 24(7):1216-23. PubMed ID: 19257822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function.
    Goode A; Long JE; Shaw B; Ralston SH; Visconti MR; Gianfrancesco F; Esposito T; Gennari L; Merlotti D; Rendina D; Rea SL; Sultana M; Searle MS; Layfield R
    Biochim Biophys Acta; 2014 Jul; 1842(7):992-1000. PubMed ID: 24642144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling.
    Goode A; Rea S; Sultana M; Shaw B; Searle MS; Layfield R
    Mol Cell Neurosci; 2016 Oct; 76():52-58. PubMed ID: 27554286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.
    Jain A; Lamark T; Sjøttem E; Larsen KB; Awuh JA; Øvervatn A; McMahon M; Hayes JD; Johansen T
    J Biol Chem; 2010 Jul; 285(29):22576-91. PubMed ID: 20452972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.
    Hocking LJ; Lucas GJ; Daroszewska A; Cundy T; Nicholson GC; Donath J; Walsh JP; Finlayson C; Cavey JR; Ciani B; Sheppard PW; Searle MS; Layfield R; Ralston SH
    J Bone Miner Res; 2004 Jul; 19(7):1122-7. PubMed ID: 15176995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
    Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
    Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.
    Foster A; Scott D; Layfield R; Rea SL
    Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel SQSTM1 mutations in patients with Paget's disease of bone in an unrelated multiethnic American population.
    Michou L; Morissette J; Gagnon ER; Marquis A; Dellabadia M; Brown JP; Siris ES
    Bone; 2011 Mar; 48(3):456-60. PubMed ID: 21073987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway.
    Copple IM; Lister A; Obeng AD; Kitteringham NR; Jenkins RE; Layfield R; Foster BJ; Goldring CE; Park BK
    J Biol Chem; 2010 May; 285(22):16782-8. PubMed ID: 20378532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of p62/SQSTM1 UBA domain mutations linked to Paget's disease of bone on ubiquitin recognition.
    Garner TP; Long J; Layfield R; Searle MS
    Biochemistry; 2011 May; 50(21):4665-74. PubMed ID: 21517082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.
    Lucas GJ; Hocking LJ; Daroszewska A; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Meier C; Hooper MJ; Ralston SH
    J Bone Miner Res; 2005 Feb; 20(2):227-31. PubMed ID: 15647816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone.
    Johnson-Pais TL; Wisdom JH; Weldon KS; Cody JD; Hansen MF; Singer FR; Leach RJ
    J Bone Miner Res; 2003 Oct; 18(10):1748-53. PubMed ID: 14584883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
    Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
    J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
    Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S
    Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p62 mutations, ubiquitin recognition and Paget's disease of bone.
    Layfield R; Cavey JR; Najat D; Long J; Sheppard PW; Ralston SH; Searle MS
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):735-7. PubMed ID: 17052185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone.
    Ciani B; Layfield R; Cavey JR; Sheppard PW; Searle MS
    J Biol Chem; 2003 Sep; 278(39):37409-12. PubMed ID: 12857745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease.
    Hocking LJ; Lucas GJ; Daroszewska A; Mangion J; Olavesen M; Cundy T; Nicholson GC; Ward L; Bennett ST; Wuyts W; Van Hul W; Ralston SH
    Hum Mol Genet; 2002 Oct; 11(22):2735-9. PubMed ID: 12374763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.